// App-Quantinova.ai

BSH2020‐PO‐034 : A study of Telomere length as a predictor for multi‐system complications and outcomes in bone marrow failure disorders

Researchers

Presenter

  • S. Gandhi

Principal Investigators

  • J. Jiang

  • S. Mansour

  • A. Kulasekararaj

  • H. Wood

  • H. Renshaw

  • C. Maharaj

  • M. Gupta

  • R. Ireland

  • G. Mufti

  • J. Marsh

Medical Centers

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Telomerase reverse transcriptase

  • Telomerase RNA component

  • Transglutaminase 2

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

  • WD Repeat Containing Antisense To TP53

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved